Market Closed

FLNA
Filana Therapeutics
$ 0.4251
-5.11%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Filana Therapeutics News

Latest Filana Therapeutics Stock News & FLNA Headlines

Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board
4 days ago | globenewswire.com
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
18 days ago | globenewswire.com
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
a month ago | globenewswire.com
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
2 months ago | benzinga.com
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
2 months ago | globenewswire.com
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
3 months ago | gurufocus.com
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
3 months ago | prnewswire.com
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
4 months ago | globenewswire.com
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
6 months ago | globenewswire.com
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

FLNA
Filana Therapeutics
$ 0.4251
-5.11%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago